Freiberg-based chemical startup CYNiO has efficiently raised over €2 million in funding capital to scale its sustainable know-how for isocyanate manufacturing and strategically increase its product portfolio.
The funding was a results of a joint funding by bmp Ventures with the IBG Innovation Fund and TGFS Technologiegründerfonds Sachsen, who convey priceless experience and networks to help CYNiO on its path to market readiness.
“Our know-how permits entry to uncommon isocyanates – safely, economically, and on demand,” says CEO Michéle Tille. “This funding is an important milestone for our workforce, bringing us one step nearer to our imaginative and prescient: to spark the event of modern finish merchandise via our chemical options,” provides CPO Marlene Baumhardt.
Based in 2025 as a spin-off of TU Bergakademie Freiberg, CYNiO specialises within the secure, versatile, and sustainable manufacturing of CO₂-based isocyanates – fully phosgene-free. The corporate develops chemical constructing blocks for analysis, trade, and specialised functions, closing a crucial hole within the worth chain.
The founding workforce behind CYNiO consists of Michéle Tille (CEO), Marlene Baumhardt (CPO) and Sophie Riedel (COO).
This innovation permits secure, versatile manufacturing of even small batches of specialized isocyanates – key constructing blocks in prescription drugs, adhesives, coatings, and foams – important to the pharmaceutical, agricultural, and development industries, amongst others.
In keeping with the corporate, the manufacturing of such specialty merchandise has been severely restricted by poisonous and rigid standard strategies, hindering innovation in each analysis and trade.
Ywes Israel, Principal at bmp Ventures, emphasises the excellent significance for the placement: “With CYNiO, one other extremely modern firm is coming to Bitterfeld-Wolfen, thus strengthening Saxony-Anhalt as a chemical location and Europe as a manufacturing location. I’m delighted that we’re capable of help the normal chemical trade into the longer term with this funding.”
The corporate’s first manufacturing facility will likely be established within the Bitterfeld-Wolfen Chemical Park in Saxony-Anhalt. From this location, CYNiO will provide the European market with new and hard-to-source isocyanates, decreasing dependence on time-consuming and dear imports. Gross sales and advertising and marketing will likely be based mostly within the area of Leipzig.
The situation was intentionally chosen with a view to bundle central capabilities in a dynamic, technology-orientated setting.
Sören Schuster, Managing Director of TGFS: “CYNiO is an impressive instance of how wonderful analysis in Saxony can result in marketable excessive know-how. As a part of the SAXEED community, the workforce constructed up entrepreneurial experience at an early stage and achieved an actual innovation leap in speciality chemical compounds. The cooperation between two Central German VC traders has made it attainable to finance this college spin-off.”
